1	En	en	SPS00	C1720294#C0332285	calificador#atributo	0-2	22_QUEST_clinical_caseMIR	SENT1	-	-
2	un	un		C0205447_1	calificador_1	3-5	22_QUEST_clinical_caseMIR	SENT1	-	-
3	paciente	paciente	NCCS000	C0030705	persona	6-14	22_QUEST_clinical_caseMIR	SENT1	-	-
4	diagnosticado	diagnosticar	VMP00SM	-	-	15-28	22_QUEST_clinical_caseMIR	SENT1	-	-
5	de	de	SPS00	C0332285	atributo	29-31	22_QUEST_clinical_caseMIR	SENT1	-	-
6	epilepsia	epilepsia	NCFS000	C0014544	trastorno	32-41	22_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
7	que	que	PR0CN000	-	-	42-45	22_QUEST_clinical_caseMIR	SENT1	-	-
8	presenta	presentar	VMIP3S0	-	-	46-54	22_QUEST_clinical_caseMIR	SENT1	-	-
9	episodios	episodio	NCMP000	C0332189	atributo	55-64	22_QUEST_clinical_caseMIR	SENT1	-	-
10	de	de	SPS00	C0332285	atributo	65-67	22_QUEST_clinical_caseMIR	SENT1	-	-
11	falta	falta	NCFS000	-	-	68-73	22_QUEST_clinical_caseMIR	SENT1	-	-
12	de	de	SPS00	C0332285	atributo	74-76	22_QUEST_clinical_caseMIR	SENT1	-	-
13	respuesta	respuesta	NCFS000	C0424540_1	entidad_observable_1	77-86	22_QUEST_clinical_caseMIR	SENT1	-	-
14	a	a	SPS00	C0424540_2	entidad_observable_2	87-88	22_QUEST_clinical_caseMIR	SENT1	-	-
15	estímulos	estímulo	NCMP000	C0424540_3	entidad_observable_3	89-98	22_QUEST_clinical_caseMIR	SENT1	-	-
16	externos	externo	AQ0MP0	C0205101	calificador	99-107	22_QUEST_clinical_caseMIR	SENT1	-	-
17	,	,	Fc	-	-	107-108	22_QUEST_clinical_caseMIR	SENT1	-	-
18	movimientos	movimiento	NCMP000	C0026649#C0026597	entidad_observable#fuerza_física	109-120	22_QUEST_clinical_caseMIR	SENT1	-	-
19	irregulares	irregular	AQ0CP0	C0205271	calificador	121-132	22_QUEST_clinical_caseMIR	SENT1	-	-
20	de	de	SPS00	C0332285	atributo	133-135	22_QUEST_clinical_caseMIR	SENT1	-	-
21	las	el	DA0FP0	-	-	136-139	22_QUEST_clinical_caseMIR	SENT1	-	-
22	cuatro	cuatro		-	-	140-146	22_QUEST_clinical_caseMIR	SENT1	-	-
23	extremidades	extremidad	NCFP000	C0015385#C1280090	estructura_corporal	147-159	22_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
24	,	,	Fc	-	-	159-160	22_QUEST_clinical_caseMIR	SENT1	-	-
25	ojos	ojo	NCMP000	C0015392#C1280202	estructura_corporal	161-165	22_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
26	cerrados	cerrar	VMP00PM	-	-	166-174	22_QUEST_clinical_caseMIR	SENT1	-	-
27	,	,	Fc	-	-	174-175	22_QUEST_clinical_caseMIR	SENT1	-	-
28	emisión	emisión	NCFS000	-	-	176-183	22_QUEST_clinical_caseMIR	SENT1	-	-
29	de	de	SPS00	C0332285	atributo	184-186	22_QUEST_clinical_caseMIR	SENT1	-	-
30	llanto	llanto	NCMS000	C0010399	hallazgo#función	187-193	22_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
31	y	y	CC	C1706368	calificador	194-195	22_QUEST_clinical_caseMIR	SENT1	-	-
32	movimientos	movimiento	NCMP000	C0026649#C0026597	entidad_observable#fuerza_física	196-207	22_QUEST_clinical_caseMIR	SENT1	-	-
33	pélvicos	pélvico	AQ0MP0	C0030797	calificador	208-216	22_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
34	,	,	Fc	-	-	216-217	22_QUEST_clinical_caseMIR	SENT1	-	-
35	de	de	SPS00	C0332285	atributo	218-220	22_QUEST_clinical_caseMIR	SENT1	-	-
36	cinco	cinco		-	-	221-226	22_QUEST_clinical_caseMIR	SENT1	-	-
37	a	a	SPS00	-	-	227-228	22_QUEST_clinical_caseMIR	SENT1	-	-
38	veinte	20	Z	-	-	229-235	22_QUEST_clinical_caseMIR	SENT1	-	-
39	minutos	min	NCMP000	-	-	236-243	22_QUEST_clinical_caseMIR	SENT1	-	-
40	de	de	SPS00	C0332285	atributo	244-246	22_QUEST_clinical_caseMIR	SENT1	-	-
41	duración	duración	NCFS000	C0449238	atributo	247-255	22_QUEST_clinical_caseMIR	SENT1	-	-
42	y	y	CC	C1706368	calificador	256-257	22_QUEST_clinical_caseMIR	SENT1	-	-
43	que	que	PR0CN000	-	-	258-261	22_QUEST_clinical_caseMIR	SENT1	-	-
44	no	no	RN	C1298908	calificador	262-264	22_QUEST_clinical_caseMIR	SENT1	-	-
45	responden	responder	VMIP3P0	-	-	265-274	22_QUEST_clinical_caseMIR	SENT1	-	-
46	al	al	SP+DA	-	-	275-277	22_QUEST_clinical_caseMIR	SENT1	-	-
47	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	278-289	22_QUEST_clinical_caseMIR	SENT1	-	-
48	con	con	SPS00	C0332287	atributo	290-293	22_QUEST_clinical_caseMIR	SENT1	-	-
49	fármacos	fármaco	NCMP000	C0355653_1	producto_1	294-302	22_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
50	antiepilépticos	antiepilépticos	NC00AO0	C0355653_2	producto_2	303-318	22_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
51	.	.	Fp	-	-	318-319	22_QUEST_clinical_caseMIR	SENT1	-	-

1	Cual	cual	PI0CS000	-	-	320-324	22_QUEST_clinical_caseMIR	SENT2	-	-
2	es	ser	VSIP3S0	-	-	325-327	22_QUEST_clinical_caseMIR	SENT2	-	-
3	el	el	DA0MS0	-	-	328-330	22_QUEST_clinical_caseMIR	SENT2	-	-
4	estudio	estudio	NCMS000	C0557651	medio_ambiente	331-338	22_QUEST_clinical_caseMIR	SENT2	-	-
5	complementario	complementario	AQ0MS0	-	-	339-353	22_QUEST_clinical_caseMIR	SENT2	-	-
6	con	con	SPS00	C0332287	atributo	354-357	22_QUEST_clinical_caseMIR	SENT2	-	-
7	mayor	mayor	AQ0CS0	C0205164#C1704243#C0549177	calificador	358-363	22_QUEST_clinical_caseMIR	SENT2	-	-
8	probabilidad	probabilidad	NCFS000	-	-	364-376	22_QUEST_clinical_caseMIR	SENT2	-	-
9	de	de	SPS00	C0332285	atributo	377-379	22_QUEST_clinical_caseMIR	SENT2	-	-
10	aclarar	aclarar	VMN0000	-	-	380-387	22_QUEST_clinical_caseMIR	SENT2	-	-
11	el	el	DA0MS0	-	-	388-390	22_QUEST_clinical_caseMIR	SENT2	-	-
12	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	391-402	22_QUEST_clinical_caseMIR	SENT2	-	-
13	.	.	Fp	-	-	402-403	22_QUEST_clinical_caseMIR	SENT2	-	-

